The Nutshell

» funding and cancer

Daily News Roundup

Most Recent

image: Influential Cancer Biologist Dies

Influential Cancer Biologist Dies

By | August 24, 2015

Chris Marshall, who pieced together a critical signaling pathway involved in cancer, has passed away at age 66.

0 Comments

image: #IceBucketChallenge Payoff

#IceBucketChallenge Payoff

By | August 20, 2015

A year after the viral ALS awareness campaign raised millions, researchers say they have something to show for the influx of funds.

0 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Annually, about 184,000 deaths annually are linked to drinking sugary beverages, according to a new study.

7 Comments

image: The Cost of Irreproducible Research

The Cost of Irreproducible Research

By | June 10, 2015

Half of basic science studies cannot be replicated, according to a new analysis—to the tune of $28 billion a year in the U.S.

5 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham